Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Immunicom Logo
Immunicom Growth Score
53
CB Rank
65258
Heat Score
56
Immunicom is a biotechnology company.
Founded
obfuscation
PrivateGrant San Diego, California, United States11-50 www.immunicom.com/
Biotechnology
Overview

Immunicom
Total Funding
obfuscation
Growth Score
53
Heat Score
56

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score53
-3 pts
in past quarter
Heat Score 56
-1 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Immunicom

CB Rank
65258
Immunicom is a biotechnology company.
Founded
obfuscation
PrivateGrant San Diego, California, United States11-50 www.immunicom.com/
Biotechnology

Funding Rounds

Grant
OBF
in
obfuscation
Series B
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Key People

Details

Legal Name Immunicom, Inc.
Operating Status Active
Company Type For Profit
Founders  Amir Jafri
About the Company
Immunicom is redefining the limits of immunotherapy through the development of innovative, non-pharmaceutical treatment approaches for cancer, inflammatory diseases, and autoimmune diseases.
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

Immunopheresis® Therapy
A blood-filtering immunotherapy that removes specific blood factors blocking the immune system to help treat cancer and other diseases.
LW-02 Cartridge
An investigational blood-filtering device used in Immunopheresis® Therapy to remove immune-blocking factors from the blood in cancer patients.

Research & Development

Immunicom is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Immunicom Logo
Grant - Immunicom
2
obfuscation
— Grant
obfuscation
Grant - Immunicom Logo
Grant - Immunicom
2
obfuscation
— Grant
obfuscation
Grant - Immunicom Logo
Grant - Immunicom
2
obfuscation
— Grant
obfuscation
Grant - Immunicom Logo
Grant - Immunicom
2
obfuscation
— Grant
obfuscation
Grant - Immunicom Logo
Grant - Immunicom
2
obfuscation
— Grant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Immunicom Logo
Grant - Immunicom
2
obfuscation
— Grant
obfuscation
Grant - Immunicom Logo
Grant - Immunicom
2
obfuscation
— Grant
obfuscation
Grant - Immunicom Logo
Grant - Immunicom
2
obfuscation
— Grant
obfuscation
Grant - Immunicom Logo
Grant - Immunicom
2
obfuscation
— Grant
obfuscation
Grant - Immunicom Logo
Grant - Immunicom
2
obfuscation
— Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
National Institutes of Health Logo
National Institutes of Health
—
Grant - Immunicom Logo
Grant - Immunicom
—
National Institutes of Health Logo
National Institutes of Health
—
Grant - Immunicom Logo
Grant - Immunicom
—
National Institutes of Health Logo
National Institutes of Health
—
Grant - Immunicom Logo
Grant - Immunicom
—
National Institutes of Health Logo
National Institutes of Health
—
Grant - Immunicom Logo
Grant - Immunicom
—
National Institutes of Health Logo
National Institutes of Health
—
Grant - Immunicom Logo
Grant - Immunicom
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 4 Contacts 12

Employee Profiles

News

News and Press

News•Oct 22, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 28, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 15, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 7, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

316
496.23%
 in past month

IT Spend

$285KThis year, Immunicom is projected to spend $285K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Data Consolidation Logo
Data Consolidation
90
Consolidate Data Logo
Consolidate Data
90
Clawbacks Logo
Clawbacks
85

Actively Used Products

15Immunicom uses 15 technology products and services including HTML5, F5 NGINX, and  Amazon EC2, according to G2 Stack.

Active Website Tech Count

6Immunicom is actively using 6 technologies for its website, according to BuiltWith. These include Font Awesome, reCAPTCHA, and  CommonCrawl Top 5m.

Total IP

16The intellectual property of Immunicom includes 14 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Immunicom has registered 2 trademarks with the most popular class being 'Medical apparatus and instruments', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Immunicom's headquarters? Immunicom is located in San Diego, California, United States.Who invested in Immunicom? Immunicom has 2 investors including National Institutes of Health and  National Cancer Institute.When was the last funding round for Immunicom? Immunicom closed its last funding round on
obfuscation
from a Grant round.Who are Immunicom's competitors? Alternatives and possible competitors to Immunicom may include Baxter International, Cerus, and  Fresenius Medical Care.How much funding has Immunicom raised to date? Immunicom has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(1fd810a 1)
|